BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 951 filers reported holding BAXTER INTL INC in Q2 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,210,000 | -7.4% | 39,912 | -0.9% | 1.08% | -18.7% |
Q2 2020 | $3,467,000 | +5.5% | 40,262 | -0.5% | 1.33% | -15.5% |
Q1 2020 | $3,285,000 | -9.2% | 40,462 | -6.5% | 1.58% | +17.5% |
Q4 2019 | $3,619,000 | -1.6% | 43,285 | +3.0% | 1.34% | -6.6% |
Q3 2019 | $3,677,000 | +6.3% | 42,035 | -0.4% | 1.44% | +5.6% |
Q2 2019 | $3,458,000 | +7.1% | 42,225 | +6.3% | 1.36% | -5.7% |
Q1 2019 | $3,230,000 | +22.0% | 39,725 | -1.2% | 1.44% | +0.8% |
Q4 2018 | $2,648,000 | -14.4% | 40,225 | +0.2% | 1.43% | -6.8% |
Q3 2018 | $3,095,000 | +3.1% | 40,150 | -1.2% | 1.53% | +1.7% |
Q2 2018 | $3,002,000 | +11.2% | 40,650 | -2.0% | 1.51% | +7.0% |
Q1 2018 | $2,699,000 | -0.1% | 41,500 | -0.7% | 1.41% | -1.8% |
Q4 2017 | $2,702,000 | +3.4% | 41,800 | +0.4% | 1.44% | +0.2% |
Q3 2017 | $2,614,000 | +3.3% | 41,650 | -0.4% | 1.43% | +3.9% |
Q2 2017 | $2,531,000 | +14.6% | 41,800 | -1.9% | 1.38% | +12.0% |
Q1 2017 | $2,209,000 | +15.2% | 42,600 | -1.4% | 1.23% | +1.4% |
Q4 2016 | $1,917,000 | -7.5% | 43,225 | -0.7% | 1.21% | -9.1% |
Q3 2016 | $2,072,000 | +4.5% | 43,525 | -0.7% | 1.34% | +4.6% |
Q2 2016 | $1,982,000 | +10.1% | 43,825 | 0.0% | 1.28% | +7.1% |
Q1 2016 | $1,800,000 | +6.5% | 43,825 | -1.1% | 1.19% | +9.7% |
Q4 2015 | $1,690,000 | +35.9% | 44,325 | +17.0% | 1.09% | +23.4% |
Q3 2015 | $1,244,000 | -53.8% | 37,875 | -1.6% | 0.88% | -51.9% |
Q2 2015 | $2,690,000 | +7.4% | 38,475 | +5.2% | 1.83% | -14.2% |
Q1 2015 | $2,505,000 | +0.6% | 36,575 | +7.7% | 2.13% | +8.8% |
Q4 2014 | $2,490,000 | +23.3% | 33,975 | +20.8% | 1.96% | +13.4% |
Q3 2014 | $2,019,000 | +55.8% | 28,135 | +56.9% | 1.73% | +56.9% |
Q2 2014 | $1,296,000 | +8.5% | 17,932 | +10.5% | 1.10% | +11.3% |
Q1 2014 | $1,194,000 | +7.1% | 16,232 | +1.2% | 0.99% | -1.0% |
Q4 2013 | $1,115,000 | – | 16,035 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |